advertisement

---

Nakamura N 15

Showing records 1 to 15 | Display all abstracts from Nakamura N

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Sakata R
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Liu M; Honjo M
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Fujishiro T; Saito H
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Yamagishi R
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Nakamura N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Igarashi N
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Nakamura N; Kurano M
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Shirato S
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Yatomi Y
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Miyamoto E
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Igarashi K
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Yamada Y
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Aihara M
Biomolecules 2022; 12:

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---